Introduction
Our goal is to develop mixtures of chemopreventive agents as inhibitors of lung cancer induction by carcinogens in tobacco smoke. Such agents could be used potentially to decrease the risk of lung cancer in high risk individuals, namely, addicted smokers and ex-smokers. This is important because lung cancer Abbreviations: B[a]P, benzo [a] pyrene; B[a]P-tetraols, r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene, r -7,t-8,9,10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a] pyrene, r -7,t-8,10,c-9-tetrahydroxy-7,8,9,10-tetrahydrobenzo-[a] pyrene, and r- 7,t-8,9,10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a] pyrene; BITC, benzyl isothiocyanate; BPDE, 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene; BPDE-N 2 -dG, N 2 - [7,8,9-trihydroxy-7,8,9 ,10-tetrahydrobenzo[a]pyrene-10-yl]deoxyguanosine; GC-NICI-MS, gas chromatography-negative ion-chemical ionization mass spectrometry; HPB, 4-hydroxy-1-(3-pyridyl)-1-butanone; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; O 6 -mG, O 6 -methylguanine; PEITC, phenethyl isothiocyanate.
is the leading cause of cancer death in the USA, with nearly 160 000 deaths expected in 2001 (1) . Unfortunately, efforts at prevention of smoking have stalled since 1990 (2) , necessitating the development of alternate approaches to prevention of tobacco-related cancer. Chemoprevention is one of these approaches.
We believe that isothiocyanates will be important components of such a chemopreventive mixture. Several isothiocyanates such as benzyl isothiocyanate (BITC), phenethyl isothiocyanate (PEITC), and sulforaphane occur naturally in cruciferous vegetables as conjugates and have impressive chemopreventive properties in animal models (3). Considerable amounts of these isothiocyanates are released when the vegetables are chewed (4, 5) . It is noteworthy in this regard that epidemiologic studies consistently demonstrate that vegetable consumption, including cruciferous vegetables, protects against lung cancer (6, 7) . Moreover, a recent nested case-control study of lung cancer indicates that isothiocyanates are protective (8) .
Among the carcinogens in tobacco smoke, benzo[a]pyrene (B[a]P) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) are believed to play significant roles as causes of lung cancer in smokers (9) . Therefore, B[a]P and NNK are our target molecules for development of a chemopreventive mixture. In the A/J mouse and F-344 rat, PEITC inhibits lung tumor induction by NNK (3), while BITC inhibits B[a]P induced lung tumorigenesis in the A/J mouse (3).
We have developed an A/J mouse lung tumor model for evaluation of chemopreventive agents (10) . In this model, mice are treated once weekly for 8 weeks by gavage with a mixture of B[a]P (3 µmol) and NNK (3 µmol). Nineteen weeks after the last treatment, the mice are killed and lung tumors are counted. This protocol typically results in about 20 lung tumors per mouse, an amount which can be decreased readily by effective chemopreventive agents. In this model, dietary PEITC (3 µmol/g diet), or BITC (1 µmol/g diet) plus PEITC (3 µmol/g diet), administered from one week prior through one week following B[a]P and NNK treatment, significantly inhibited lung tumor multiplicity by~40% (11) . No inhibition was observed with BITC (1 µmol/g diet) alone, nor did dietary PEITC inhibit B[a]P tumorigenesis in this model, leading us to conclude that the observed inhibition by dietary isothiocyanates was due mainly to the effect of PEITC on tumor induction by NNK.
Previous studies demonstrate the importance of DNA adduct formation in A/J mouse lung tumor induction by B[a]P or NNK (12) (13) (14) . However, there are no reports in the literature on DNA adduct formation by a mixture of B[a]P and NNK. Experiments carried out in rats and mice indicate that one of the main mechanisms by which isothiocyanates inhibit tumorigenesis is favorable modification of carcinogen metabolism leading to decreased DNA adduct formation (3, 15, 16) . Therefore, our hypothesis in this study was that chemoprevention by dietary BITC plus PEITC was due to reduction in DNA adduct formation by B[a]P and/or NNK. In this paper, we report the results of our experiments to test this hypothesis. 
Materials and methods

Chemicals
Animal studies
Female A/J mice were obtained at age 5-6 weeks from Jackson Laboratories (Bar Harbor, ME). They were housed under standard conditions and maintained on AIN-93G diet (Dyets, Bethlehem, PA). The mice were 7 weeks of age at the time treatments were initiated.
In experiment 1, there were 12 groups of nine mice each. Mice were treated weekly by gavage with either NNK (3 µmol in 0.1 ml cottonseed oil; groups 1, 5 and 9), B[a]P (3 µmol in 0.1 ml cottonseed oil; groups 2, 6 and 10), B[a]P plus NNK (3 µmol each in 0.1 ml cottonseed oil; groups 3, 7 and 11); or 0.1 ml cottonseed oil alone (groups 4, 8 and 12) . Mice were killed 24 h after 1 (groups 1-4), 4 (groups 5-8) or 8 (groups 9-12) treatments. Lungs were harvested from each group and divided into three pools of three lungs each. They were frozen in liquid nitrogen and stored at -80°C until the DNA was isolated as described below.
In experiment 2, 90 mice were divided into 10 groups of nine, and were treated weekly for 4 weeks by gavage with B[a]P plus NNK (3 µmol each in 0.1 ml cottonseed oil). The mice in each group were killed 2, 4, 6, 12, 24, 48, 72, 120, 192, or 384 h after the fourth dose of B[a]P plus NNK. At sacrifice, lungs from each group were isolated and stored at -80°C until isolation of DNA.
In experiment 3, 126 mice were divided into 21 groups of six mice each. All mice were treated with B[a]P plus NNK (3 µmol each in 0.1 ml cottonseed oil by gavage). Control animals had nothing added to their diets. Groups of six of the control mice were killed 4, 24, or 120 h after a single dose of B[a]P plus NNK, or 24 or 120 h after 4 weekly doses of B[a]P plus NNK, or 24 or 120 h after 8 weekly doses of B[a]P plus NNK. The animals treated with PEITC were given PEITC in AIN-93G diet (3 µmol/g diet) from 1 week before carcinogen treatment until killing, and groups of six mice were killed at the same intervals used for the control mice. The animals treated with BITC plus PEITC were given BITC (1 µmol/g diet) plus PEITC (3 µmol/g diet) from 1 week before carcinogen treatment until killing, and groups of six mice were killed at the same intervals used for the control mice. Food consumption was monitored using metal boxfeeders (18) . The diets were prepared monthly and stored at 4°C. At killing, lungs from each group of mice were divided into three pools of two lungs each and stored at -80°C until DNA isolation.
Isolation of DNA from tissues DNA was isolated by modifications of the Kirby method (19) . In brief, the tissues were homogenized in 50 mM Tris, 1 mM EDTA, pH 7.4 and incubated with 1% sodium dodecyl sulfate and proteinase K (300 µg/ml). The homogenates were extracted twice with phenol/chloroform/isoamyl alcohol (25:24:1) and then once with chloroform/isoamyl alcohol (24:1). DNA was precipitated with ethanol and dissolved in 15 mM sodium citrate, 15 mM sodium chloride, 1 mM EDTA, pH 7.4. The DNA was incubated with RNase A (100 µg/ml) and RNase T1 (2000 U), extracted once with chloroform/ isoamyl alcohol, and precipitated with ethanol. DNA was dried under a stream of nitrogen and stored at -20°C.
Fluorometric analysis of N 2 - [7,8,9-trihydroxy-7,8,9,10- (20) . Briefly, the DNA, free of unbound B[a]P-tetraols, was dissolved in H 2 O and the DNA concentration was determined by UV to insure sufficient purity and amount of DNA for analysis. The DNA was hydrolyzed by incubation at 80°C for 4 h in a final concentration of 0.1 N HCl. This treatment releases BPDE-N 2 -dG as B[a]P-tetraols, predominantly the r- 7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a] pyrene isomer. The hydrolysates were stored at -20°C until analyzed by HPLC with fluorescence detection. Silanized, amber, high recovery autosampler vials 1434 were prepared so that the equivalent of 75 µg DNA would be injected in a 900 µl injection. The total volume in each autosampler vial was brought to 1.0 ml with H 2 O.
HPLC analysis was performed with a Hewlett Packard Series 1100 autosampler coupled to a Waters Millipore automated gradient controller and model 510 solvent delivery system. All solvents were sonicated under vacuum prior to use and continuously sparged with high purity helium throughout the analyses. The B[a]P-tetraols were concentrated by an initial 10 min 35% methanol in H 2 O isocratic elution over a guard column and a Beckman Ultrasphere (Fullerton, CA) ODS 4.6 mm ϫ 4.5 cm precolumn at 1.0 ml/min. The concentrated B[a]P-tetraols were then eluted from the precolumn by a 30 min, 35-100% methanol linear gradient. The gradient solvents were switched by a Valco Instruments switching valve to flow over a Beckman Ultrasphere ODS 4.6 mm ϫ 25 cm analytical column to separate the four B[a]P-tetraol isomers. The B[a]P-tetraols were detected by an Shimadzu (Columbia, MD) RF-10AXL fluorescence detector linked to a PeakSimple (Alltech Deerfield, IL) Chromatography Data System. The fluorescence excitation wavelength was set at 344 nm and the emission wavelength at 398 nm. The fluorescence corresponding to the eluted peaks of each B[a]Ptetraol isomer was integrated. The level of each B[a]P-tetraol isomer in the samples was determined by comparison with a standard curve generated from the fluorescence areas of authentic B[a]P-tetraol standards analyzed prior to and immediately following the analysis of a set of samples. At 12 h intervals throughout the analysis of a set of samples, the fluorescence area of a B[a]Ptetraol standard was analyzed to validate use of the standard curve. The detection limit was 2 fmol B[a]P-tetraol. The DNA from each lung was analyzed for released B[a]P-tetraols in single HPLC runs. The same DNA samples were analyzed for guanine. The levels of B[a]P-tetraols released from DNA were expressed as pmol/µmol guanine.
Fluorometric analysis of O 6 -methylguanine (O 6 -mG) in DNA
The method is similar to that described previously (12) . Briefly, DNA was dissolved in 10 mM sodium cacodylate buffer, pH 7.0, and the DNA concentration was determined by UV. The solution was heated at 100°C for 30 min to release 7-methylguanine. The partially apurinic DNA was precipitated with 0.1 N HCl. The precipitated DNA was hydrolyzed in 0.1 N HCl at 80°C for 1.5 h, transferred to 2 ml high recovery silanized autosampler vials and analyzed by HPLC with fluorescence detection for O 6 -mG. O 6 -mG was eluted from two Whatman Partisil (Clifton, NI)10 SCX columns in tandem with an isocratic solution of 100 mM ammonium phosphate, pH 2.0, and 5% methanol at 1.0 ml/min. Buffer was filtered through a 0.2 µm nylon membrane and sonicated under vacuum prior to use. The concentration of the buffer and/or the percentage of methanol added to the buffer were altered as the columns aged so that the retention time of O 6 -mG was~30 min. O 6 -mG was detected by fluorescence (excitation 286 nm, emission 366 nm). The level of O 6 -mG in each sample was determined by comparison with a standard curve generated from the fluorescence areas of O 6 -mG standard analyzed prior to and immediately following the analysis of a set of samples. The detection limit for O 6 -mG was 1 pmol. The DNA from each lung was analyzed for O 6 -mG in a single HPLC run. The same DNA samples were also analyzed for guanine. The levels of O 6 -mG released from DNA were expressed as pmol/µmol guanine.
Gas chromatography-negative ion chemical ionization-mass spectrometry (GC-NICI-MS) analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) released from DNA
The procedure was performed essentially as previously described (21) . Briefly, lung DNA was dissolved in H 2 O and the DNA concentration was determined by UV. An average of 94 Ϯ 53 mg DNA was analyzed. Fifty pg (299 fmol) [4,4-D 2 ]HPB as internal standard was added to each sample and the DNA was hydrolyzed by incubation at 80°C for 3 h in a final concentration of 0.8 N HCl in a total volume of 1.0 ml. A 50 µl aliquot from each hydrolyzed sample was reserved for analysis of guanine. The aqueous solution of DNA was extracted twice with CH 2 Cl 2 . The aqueous layer was saved and the pH was adjusted to 7.0 with 1 N NaOH. The sample was then extracted twice with equal volumes of CH 2 Cl 2 , the organic layers were pooled and the solvent removed with a SpeedVac (Holbrook, NY) concentrator. The residue, containing HPB, was dissolved in 0.5 ml of CH 2 Cl 2 . Derivatization was carried out in a hexane solution of trimethylamine freshly prepared as follows: 240 mg trimethylamine hydrochloride dissolved in 20 ml 0.8 N NaOH, and extracted with 20 ml hexane. The hexane layer was dried (Na 2 SO 4 ). One ml of this solution was added to each sample. The reaction was started by adding 0.5 ml pentafluorobenzoyl chloride solution (20 µl pentafluorobenzoyl chloride in 10 ml CH 2 Cl 2 ) and was carried out for 1 h at room temperature. The solvent was removed using a SpeedVac concentrator.
Unreacted pentafluorobenzoyl chloride was removed from the samples by reverse phase HPLC. The HPLC conditions were as follows: a 4.6 mm ϫ 12.5 cm Whatman Partisil 5 ODS 3 column was eluted with a 
Fluorometric analysis of guanine
This method is similar to that described previously (20) . Guanine from about 2 µg DNA per injection was eluted from two Whatman Partisil 10 SCX columns in tandem with an isocratic solution of 100 mM ammonium phosphate, pH 2.0, at 1.0 ml/min. Buffer was filtered through a 0.2 µm nylon membrane and sonicated under vacuum prior to use. Detection was by fluorescence (excitation 286 nm, emission 366 nm). The level of guanine in each sample was determined by comparison with a standard curve generated from the fluorescence areas of guanine standards analyzed at 12 h intervals throughout the analysis of a set of samples. Determinations were carried out in duplicate, with variations typically Ͻ2%.
Statistical analysis
Comparisons between DNA adduct levels in different treatment groups were made using Student's t-test.
Results
The prevalent established pathway of DNA adduct formation by B[a]P yields BPDE-N 2 -dG ( Figure 1) (22) . This adduct was measured in the lung DNA of B[a]P-treated mice by acid hydrolysis of the DNA followed by HPLC-fluorometric quantitation of the released B[a]P-tetraols. NNK forms DNA adducts by two main pathways (Figure 1) (23) . α-Hydroxylation at the methylene carbon leads to methyl DNA adducts, among which O 6 -mG is thought to be important in tumor induction in mice. This adduct was quantified by HPLC-fluorometry.
α-Hydroxylation at the methyl carbon of NNK produces pyridyloxobutyl DNA adducts, which can be hydrolyzed to HPB. The released HPB was quantified by GC-NICI-MS.
In experiment 1, our goal was to determine whether formation of these adducts in pulmonary DNA was different when B[a]P and NNK were administered to A/J mice individually Figure 2B shows that O 6 -mG was detected only in mice treated with NNK or B[a]P plus NNK. Adduct levels increased significantly between 1 and 4 weeks (P Ͻ 0.05) and were similar after 4 and 8 weeks of treatment. There were no significant effects of B[a]P on O 6 -mG levels. Figure 2C shows similar results for HPB-releasing adducts, although there was no significant increase in adduct levels with time, probably due to the relatively large variation. A small amount of HPB was detected in the lung DNA of the group treated once with B[a]P, presumably due to assay background. Collectively, the results of this experiment demonstrate that adduct formation by B[a]P and NNK is similar when the compounds are administered individually compared to when they are given together.
In experiment 2, we evaluated the time course of adduct persistence after 4 weeks of treatment with B[a]P plus NNK. We chose the 4 week time point because the results of experiment 1 indicated that adduct formation had reached a plateau at that point. However, we needed further information on adduct persistence to determine the appropriate sacrifice intervals after B[a]P plus NNK treatment. The results of this experiment, in which B[a]P-tetraols released from BPDE-N 2 -dG, and O 6 -mG, were quantified, are summarized in Figure 3A ,B. Levels of B[a]P-tetraols and O 6 -mG did not change markedly over the entire 2-384 h time course.
These results set the stage for experiment 3, the design of which is illustrated in Figure 4 . PEITC or BITC plus PEITC were administered in the diet. The 24 h and 120 h sacrifice intervals after 4 and 8 weeks of treatment were chosen based on the results of experiment 2. We also included a 4 h sacrifice interval after the first treatment because previous studies had shown that O 6 -mG formation peaked at this time point after one treatment with NNK (12) . B[a]P-tetraols, O 6 -mG, and HPB-releasing adducts were quantified.
The results are summarized in Figure 5A -I. Figure 5A shows little effect of dietary PEITC or BITC plus PEITC on B[a]P-tetraols after one treatment with B[a]P plus NNK; a small but significant increase was seen at the 120 h interval. Similar results were observed after 4 and 8 weeks ( Figure 5B,C) . Figure 5D -F show no significant effect of dietary isothiocyanates on O 6 -mG levels. There were apparent increases in some groups, but these were not significant. Figure 5G -I demonstrate decreases, some significant (P Ͻ 0.05), in levels of HPB-releasing adducts in most groups of mice treated with dietary PEITC, or BITC plus PEITC, for 4 or 8 weeks.
Discussion
The results of this study partially support our hypothesis that isothiocyanates diminish levels of DNA adducts, thereby decreasing B[a]P plus NNK-induced lung tumorigenesis. Levels of HPB-releasing DNA adducts of NNK decreased in several of the groups treated with dietary PEITC, or dietary BITC plus PEITC, and it was these treatments that provided the greatest protection against lung tumor development in our earlier experiments (11) . Inhibition of adduct formation was particularly consistent at the 24 h time points (Figure 5G-I) . These results support the proposal, based on the results of the tumor inhibition studies, that inhibition of B[a]P plus NNKinduced lung tumorigenesis by dietary PEITC is due mainly to the effect of PEITC on NNK. Inhibition of tumor formation in this model was the same when either dietary PEITC, or a mixture of dietary BITC and PEITC, was used, and dietary BITC had no effect. In addition, dietary PEITC had no effect on lung tumor induction by B[a]P (11). The results presented here demonstrate that dietary PEITC, or BITC plus PEITC, had similar inhibitory effects on HPB-releasing adducts of NNK. Moreover, dietary PEITC had no inhibitory effect on BPDE-N 2 -dG levels. Collectively, these results demonstrate a role for HPB-releasing DNA adducts of NNK in tumorigenesis in this model and indicate that inhibition of this pathway is important in chemoprevention by dietary PEITC.
Previously, we demonstrated that inhibition of HPB-releasing adducts of NNK is the major mechanism by which PEITC inhibits lung tumorigenesis in F344 rats treated with PEITC and NNK (24) . In that study, PEITC was administered in the diet at 3 µmol/g diet while NNK was given three times weekly for 20 weeks by subcutaneous injection. HPB-releasing DNA adducts of NNK were measured in DNA of pulmonary cell types and whole lung at various intervals during NNK and PEITC treatment. Consistent decreases in levels of HPBreleasing adducts were seen in the presumed target cellsalveolar type II cells-as well as in Clara cells and whole lung. The inhibitory effects were stronger than in the present study, but each dose of NNK (1.76 mg/kg body wt) was lower than used here (31 mg/kg body wt), while the doses of PEITC per g diet were the same. In another study, dietary PEITC significantly decreased levels of HPB releasing hemoglobin adducts formed in rats treated with 2 p.p.m. NNK in the drinking water (25) . Our results, which demonstrate a role for dietary PEITC-mediated inhibition of HPB-releasing DNA adducts of NNK in the mouse model used here, are thus consistent with our previous data in the rat.
The null effect of the isothiocyanate treatments on O 6 -mG levels was quite surprising. Previous studies demonstrated convincingly that O 6 -mG is important in lung tumorigenesis in A/J mice treated with a single dose of NNK, and that O 6 -mG levels can be decreased by PEITC (12, 26, 27) . However, the protocols and doses used were different from those employed here. Morse et al. treated mice for four consecutive days with 5 or 25 µmol of PEITC by gavage, followed 2 h later by 10 µmol of NNK by i.p. injection (27) . Levels of O 6 -mG, 2 h and 6 h after NNK treatment, were significantly decreased by PEITC. In a second study, four consecutive gavage doses of 1 µmol of PEITC had no effect on O 6 -mG levels in mice treated 2 h later with 10 µmol of NNK by gavage, then killed after 6 h (26). In the present study, there was also no effect of dietary PEITC (~6 µmol/day for 7 days 1437 prior to treatment with NNK plus B[a]P) on O 6 -mG levels 4, 24, or 120 h after the first carcinogen treatment. The total dose of PEITC,~42 µmol, was greater than the total 20 µmol gavage dose in Morse et al. (27) , yet we observed no inhibition of O 6 -mG in mice killed 4 h after B[a]P plus NNK treatment (compared with 2 or 6 h in Morse et al.) . In unpublished work, we observed no effects of gavaged PEITC or BITC plus PEITC (doses ranging from 6-12 µmol per mouse) on O 6 -mG levels in the lungs of A/J mice treated 2 h later with B[a]P plus NNK and killed at the same intervals as used here. Apparently, B[a]P in some way prevents the PEITC-mediated inhibition of O 6 -mG levels from NNK. B[a]P does not seem to directly affect O 6 -mG formation from NNK ( Figure 2) . B[a]P may compete with NNK for the active site of a cytochrome P450 enzyme, diverting NNK α-methylene hydroxylation to another enzyme that is not affected by PEITC. The mechanism of this surprising observation requires further study.
We did not observe any consistent effects of dietary PEITC or BITC plus PEITC on BPDE-N 2 -dG levels in mouse lung. The null effect of PEITC is consistent with the results of our tumor study, which clearly demonstrated no effect of dietary PEITC on lung tumor induction by B (28) . They also observed no effect of PEITC on tumorigenesis by B[a]P. Collectively, it is clear that PEITC has little or no effect on B[a]P-DNA adduct formation or tumorigenicity.
In this study, inhibition of DNA adduct formation, when observed, was relatively modest. These results suggest that there are effects of isothiocyanates other than modification of DNA adduct formation that are important in chemoprevention. Prominent among these is induction of apoptosis. There is now a considerable body of evidence indicating that isothiocyanates induce apoptosis in various systems. BITC and PEITC both induce sustained activation of c-Jun N-terminal kinase, and this is associated with induction of apoptosis in various cell types (29) . Treatment with isothiocyanates under conditions of apoptosis induction causes rapid and transient induction of caspase-3/CPP32-like activity (30) . As discussed above, PEITC induces apoptosis in JB6 cells through a p53-dependent pathway (31) . PEITC induces apoptosis in human leukemia cells and inhibits cell growth in this system (32, 33) . A recent study demonstrates that PEITC further increases apoptosis induced in the respiratory tract of rats by cigarette smoke (34) . BITC and sulforaphane, a related naturally occurring isothiocyanate, as well as other phase II enzyme inducers, induce apoptosis in human colon cancer cells (35, 36) . Future studies should examine the role of apoptosis induction under conditions of inhibition of tumorigenesis by isothiocyanates.
There were some limitations to this study. First, we examined only three specific DNA adducts. While there is substantial evidence that these adducts are important in carcinogenesis by B[a]P and NNK, it is possible that other adducts, not measured here, may also contribute. For example, depurinating adducts of B[a]P, and O 4 -methylthymidine from NNK, may be involved in tumorigenesis (37, 38) . There are other DNA adducts of B[a]P that are unidentified (39, 40) . In addition, we measured HPB-releasing adducts as a class, but individual pyridyloxobutylating adducts, such as O 6 -[4-oxo-4-(3-pyridyl)butyl] deoxyguanosine, may be important (41) . All of our adduct measurements were carried out in whole lung, but it is possible that adducts in individual cell types may be modified differently, thus obscuring the overall effect (24) .
In summary, the results of this study partially support our hypothesis that modification of DNA adduct levels is involved in inhibition of B[a]P plus NNK-induced pulmonary tumorigenesis by dietary isothiocyanates in the A/J mouse. However, the effects we observed were generally modest. The results indicate that protective mechanisms other than modification of DNA adduct formation contribute to inhibition of pulmonary carcinogenesis in this model.
